Evidence map›Paper›PMID 34630427›Full record

ArticleFrontiers in immunology2021

Profile of Immunoglobulin G

Haifeng Hou, Huan Yang, Pengcheng Liu, Changwu Huang, Meng Wang, Yuejin Li, Mingsong Zhu, Jing Wang, Yuan Xu, Youxin Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Haifeng HouSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Huan YangSchool of Clinical Medicine, Southwest Medical University, Luzhou, China.
Pengcheng LiuSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Changwu HuangDepartment of Clinical Laboratory, The Fifth People's Hospital of Chongqing & Chongqing Renji Hospital, University of Chinese Academy of Sciences, Chongqing, China.
Meng WangSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Yuejin LiSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Mingsong ZhuDepartment of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.
Jing WangDepartment of Clinical Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Yuan XuDepartment of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.
Youxin WangBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Qingwei MaTesting Center, Bioyong Technologics, Inc., Beijing, China.
Dong LiSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Pu LiaoDepartment of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.
Wei WangSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Shandong First Medical University · CNFirst People's Hospital of Chongqing · CNBeijing Biocytogen (China) · CNCapital Medical University · CNChongqing Public Health Medical Center · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) remains a major health challenge globally. Previous studies have suggested that changes in the glycosylation of IgG are closely associated with the severity of COVID-19. This study aimed to compare the profiles of IgG

Indexed as

AdultAntibody-Dependent Cell CytotoxicityCase-Control StudiesChromatography, High Pressure LiquidComplement Pathway, Mannose-Binding LectinCOVID-19FemaleGlycoproteinsGlycosylationHumansImmunoglobulin GMaleMiddle AgedPhenotypeSARS-CoV-2Glycoproteinsglycosylated IgGImmunoglobulin Gcase-control studyCOVID-19glycosylationIgGSARS-CoV-2

Identifiers

PMID34630427
PMCPMC8495247
OpenAlexW3202639981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.